Literature DB >> 21041835

Perception of smoking risks and motivation to quit among nontreatment-seeking smokers with and without schizophrenia.

Deanna L Kelly1, Heather G Raley, Suzanne Lo, Katherine Wright, Fang Liu, Robert P McMahon, Eric T Moolchan, Stephanie Feldman, Charles M Richardson, Heidi J Wehring, Stephen J Heishman.   

Abstract

OBJECTIVE: We examined perceived consequences/benefits of cigarette smoking and motivation for quitting in nontreatment-seeking smokers who had schizophrenia or schizoaffective disorder (N = 100) or had no Axis I psychiatric disorder (normals, N = 100).
METHODS: Participants completed questionnaires and provided a breath carbon monoxide (CO) sample 10-15 minutes after smoking 1 preferred-brand cigarette. Primary assessments included the Smoking Consequences Questionnaire-Adult, the Reasons for Quitting Scale, and the Stages of Change.
RESULTS: There were no differences between the schizophrenia and control group in mean age of smoking onset (16.2 ± 5.4 vs 15.6 ± 5.5 y, P = .44), number of cigarettes daily (17.9 ± 11.6 vs 17.0 ± 7.9, P = 0.51), or in breath CO (28.0 ± 14.5 vs 22.9 ± 8.0 ppm, P = .61). Compared with normals, people with schizophrenia report greater stimulation/state enhancement (P < .0001) and social facilitation (P < .004) from smoking. People with schizophrenia had less appreciation of health risks associated with smoking than normal controls (P < .0001) and were less motivated to quit smoking than normal controls (P = .002), even though they were as likely to be in the preparation stage of change. Immediate reinforcement (P = .04) and health concerns (P = .002) were rated lower as motivators for considering quitting smoking in schizophrenia than normals. People with schizophrenia reported greater motivation to stop smoking due to social pressure/rewards than normals (P = .047).
CONCLUSIONS: This study underscores the degree to which people with schizophrenia perceive the state-enhancing effects of smoking and their lower appreciation for health risks of smoking compared with normal controls.

Entities:  

Mesh:

Year:  2010        PMID: 21041835      PMCID: PMC3330003          DOI: 10.1093/schbul/sbq124

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  40 in total

1.  A focus group pilot study of tobacco smoking among psychosocial rehabilitation clients.

Authors:  A Lucksted; L B Dixon; J B Sembly
Journal:  Psychiatr Serv       Date:  2000-12       Impact factor: 3.084

2.  Determinants of smoking behaviour in outpatients with schizophrenia.

Authors:  A Herrán; A de Santiago; M Sandoya; M J Fernández; J F Diez-Manrique; J L Vázquez-Barquero
Journal:  Schizophr Res       Date:  2000-01-21       Impact factor: 4.939

3.  Smoking and schizophrenia: is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use?

Authors:  Mark Barnes; Bruce R Lawford; Simon C Burton; Karen R Heslop; Ernest P Noble; Karrin Hausdorf; Ross McD Young
Journal:  Aust N Z J Psychiatry       Date:  2006 Jun-Jul       Impact factor: 5.744

Review 4.  Cognitive effects of nicotine.

Authors:  A H Rezvani; E D Levin
Journal:  Biol Psychiatry       Date:  2001-02-01       Impact factor: 13.382

5.  Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland.

Authors:  C Kelly; R G McCreadie
Journal:  Am J Psychiatry       Date:  1999-11       Impact factor: 18.112

6.  The effects of smoking high nicotine cigarettes on prepulse inhibition, startle latency, and subjective responses.

Authors:  K E Hutchison; R Niaura; R Swift
Journal:  Psychopharmacology (Berl)       Date:  2000-06       Impact factor: 4.530

7.  Self-efficacy and motivation to quit during participation in a smoking cessation program.

Authors:  Thuy Boardman; Delwyn Catley; Matthew S Mayo; Jasjit S Ahluwalia
Journal:  Int J Behav Med       Date:  2005

8.  A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder.

Authors:  Amanda Baker; Robyn Richmond; Melanie Haile; Terry J Lewin; Vaughan J Carr; Rachel L Taylor; Sylvia Jansons; Kay Wilhelm
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

9.  Cigarette smoking and mortality risk in people with schizophrenia.

Authors:  Deanna L Kelly; Robert P McMahon; Heidi J Wehring; Fang Liu; Kristen M Mackowick; Douglas L Boggs; Kimberly R Warren; Stephanie Feldman; Joo-Cheol Shim; Raymond C Love; Lisa Dixon
Journal:  Schizophr Bull       Date:  2009-12-17       Impact factor: 9.306

10.  Schizophrenia and the motivation for smoking.

Authors:  Cheryl Forchuk; Ross Norman; Ashok Malla; Mary-Lou Martin; Terry McLean; Stephen Cheng; Kristine Diaz; Elizabeth McIntosh; Ann Rickwood; Sandra Vos; Cynthia Gibney
Journal:  Perspect Psychiatr Care       Date:  2002 Apr-Jun       Impact factor: 2.186

View more
  19 in total

1.  Predictors of the Perception of Smoking Health Risks in Smokers With or Without Schizophrenia.

Authors:  William J Kowalczyk; Heidi J Wehring; George Burton; Heather Raley; Stephanie Feldman; Stephen J Heishman; Deanna L Kelly
Journal:  J Dual Diagn       Date:  2016-11-18

Review 2.  Treatment of tobacco dependence in people with mental health and addictive disorders.

Authors:  Kristen M Mackowick; Marie-Josee Lynch; Andrea H Weinberger; Tony P George
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

Review 3.  Exploring Issues of Comorbid Conditions in People Who Smoke.

Authors:  Alana M Rojewski; Stephen Baldassarri; Nina A Cooperman; Ellen R Gritz; Frank T Leone; Megan E Piper; Benjamin A Toll; Graham W Warren
Journal:  Nicotine Tob Res       Date:  2016-01-17       Impact factor: 4.244

4.  Smoking among individuals with schizophrenia in Korea: gender differences.

Authors:  Sun S Kim; Sangkeun Chung; Jong-Il Park; Ae-Ja Jung; David Kalman; Douglas M Ziedonis
Journal:  Arch Psychiatr Nurs       Date:  2013-07-26       Impact factor: 2.218

Review 5.  Achieving Smoking Cessation in Individuals with Schizophrenia: Special Considerations.

Authors:  Corinne Cather; Gladys N Pachas; Kristina M Cieslak; A Eden Evins
Journal:  CNS Drugs       Date:  2017-06       Impact factor: 5.749

6.  Antipsychotic Treatment and Tobacco Craving in People With Schizophrenia.

Authors:  Heidi J Wehring; Stephen J Heishman; Robert P McMahon; Fang Liu; Stephanie Feldman; Heather Raley; Elaine Weiner; Deanna L Kelly
Journal:  J Dual Diagn       Date:  2017 Jan-Mar

7.  Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ dataset.

Authors:  Romain Rey; Thierry D'Amato; Laurent Boyer; Lore Brunel; Bruno Aouizerate; Fabrice Berna; Delphine Capdevielle; Isabelle Chereau; Gabrielle Chesnoy-Servanin; Hélène Denizot; Jean-Michel Dorey; Caroline Dubertret; Julien Dubreucq; Catherine Faget; Franck Gabayet; Christophe Lancon; Jasmina Mallet; David Misdrahi; Christine Passerieux; Aurélie Schandrin; Franck Schürhoff; Mathieu Urbach; Pierre Vidailhet; Pierre-Michel Llorca; Guillaume Fond
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-07       Impact factor: 5.270

Review 8.  Interventions for smoking cessation and reduction in individuals with schizophrenia.

Authors:  Daniel T Tsoi; Mamta Porwal; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

9.  Socio-demographic and clinical characteristics of heavy and non-heavy smokers among schizophrenia inpatients in a Chinese Han population.

Authors:  Xiang Yang Zhang; Da Chun Chen; Yun Long Tan; Mei Hong Xiu; Jingyi Cui; Li Hui; Fu De Yang; Thomas R Kosten
Journal:  Psychopharmacology (Berl)       Date:  2013-08-21       Impact factor: 4.530

10.  Smoking Cessation in Individuals With Serious Mental Illness: A Randomized Controlled Trial of Two Psychosocial Interventions.

Authors:  Melanie E Bennett; Clayton H Brown; Lan Li; Seth Himelhoch; Alan Bellack; Lisa Dixon
Journal:  J Dual Diagn       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.